A new study has uncovered a biological link between inflammation and motivational deficits in people with schizophrenia, identifying a promising treatment target for symptoms that current medications fail to address. Higher levels of the inflammatory marker C-reactive protein were associated with reduced activity in brain regions involved in reward and motivation, such as the ventral striatum and ventromedial prefrontal cortex.
A new study has uncovered a biological link between inflammation and motivational deficits in people with schizophrenia, identifying a promising treatment target for symptoms that current medications fail to address. Higher levels of the inflammatory marker C-reactive protein were associated with reduced activity in brain regions involved in reward and motivation, such as the ventral striatum and ventromedial prefrontal cortex.
Share this Article
Recommended